Princeton Capital Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Princeton Capital Management’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3	Closed	-$1K	–	234
2019 Q3	$1K	Hold	3	–	–	﹤0.01%	243
2019 Q2	$1K	Hold	3	–	–	﹤0.01%	244
2019 Q1	$1K	Hold	3	–	–	﹤0.01%	239
2018 Q4	$1K	Hold	3	–	–	﹤0.01%	254
2018 Q3	$1K	Hold	3	–	–	﹤0.01%	259
2018 Q2	$1K	Hold	3	–	–	﹤0.01%	290
2018 Q1	$1K	Buy	+3	New	+$1.49K	﹤0.01%	287
2014 Q2	–	Sell	-4	Closed	-$15K	–	99
2014 Q1	$15K	Hold	4	–	–	0.01%	95
2013 Q4	$14K	Hold	4	–	–	0.01%	93
2013 Q3	$14K	Hold	4	–	–	0.01%	94
2013 Q2	$36K	Buy	+4	New	+$44.3K	0.03%	96

Other funds holding FRTX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MFG

Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Princeton Capital Management's FRTX Position: Q4 2019 in Review

Princeton Capital Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2019, closing a stake of 3 shares — an estimated $1K sold.

Princeton Capital Management first reported a position in FRTX in Q2 2013 and held it in 11 quarters. The position peaked at $36K in Q2 2013. 12 funds tracked by Wall St. Rank hold FRTX as of Q4 2019.

Princeton Capital Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Princeton Capital Management sold 3 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $1K.
Princeton Capital Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 11 quarters.
Princeton Capital Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $36K in Q2 2013.
12 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Princeton Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.